Q1 2022 Autolus Therapeutics PLC Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Autolus Therapeutics First Quarter 2022 Financial Results conference call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Olivia Manser, Director of Investor Relations. Please go ahead ma'am.
Thank you, and Good morning or good afternoon everyone, and thank you for joining us to take part in today's call on the Operational Highlights and Financial Results for the first quarter of 2022. I am Olivia Manser, Director of Investor Relations, and with me today are Dr. Christian Itin, our Chief Executive Officer, and Dr. Lucinda Crabtree, our Chief Financial Officer.
Before we begin, I would like to remind you that during today's call our discussion will contain forward looking statements. Please make sure you're familiar with our disclaimer, which is on Slide 2 of the presentation. On Slide 3, you will see the agenda for today, which is as follows:
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |